BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15692481)

  • 1. Insulin resistance, acanthosis nigricans, and hypertriglyceridemia.
    Eberting CL; Javor E; Gorden P; Turner ML; Cowen EW
    J Am Acad Dermatol; 2005 Feb; 52(2):341-4. PubMed ID: 15692481
    [No Abstract]   [Full Text] [Related]  

  • 2. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.
    Agarwal AK; Arioglu E; De Almeida S; Akkoc N; Taylor SI; Bowcock AM; Barnes RI; Garg A
    Nat Genet; 2002 May; 31(1):21-3. PubMed ID: 11967537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.
    Simha V; Garg A
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5433-7. PubMed ID: 14602785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acanthosis nigricans and hyperandrogenism in a pregnancy complicated by diabetes.
    Gemer O; Segal S; Segal O; Zohav E; Sassoon E
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):810-1. PubMed ID: 8469481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
    Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
    Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipodystrophies-Disorders of the Fatty Tissue.
    Knebel B; Müller-Wieland D; Kotzka J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acanthosis nigricans, hirsutism and insulin-resistant diabetes].
    Colle M; Doyard P; Chaussain JL; Battin J; Job JC
    Arch Fr Pediatr; 1979 May; 36(5):518-23. PubMed ID: 496546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperandrogenism: new insights into diagnosis and therapy.
    Barbieri RL
    Curr Opin Obstet Gynecol; 1991 Jun; 3(3):316-25. PubMed ID: 1813000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acanthosis nigricans with etretinate (Tigason) in a patient with Lawrence-Seip syndrome (generalized lipodystrophy).
    Mørk NJ; Rajka G; Halse J
    Acta Derm Venereol; 1986; 66(2):173-4. PubMed ID: 2424246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired and inherited lipodystrophies.
    Garg A
    N Engl J Med; 2004 Mar; 350(12):1220-34. PubMed ID: 15028826
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
    Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recognize rare diseases by the adipose tissue : Lipodystrophy-actually simple but nevertheless often overlooked].
    Wabitsch M; V Schnurbein J
    Internist (Berl); 2020 Oct; 61(10):1063-1075. PubMed ID: 32930809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of congenital generalized lipodystrophy.
    Agarwal AK; Barnes RI; Garg A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):336-9. PubMed ID: 14557833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies.
    Kellett HA; Collier A; Taylor R; Sawers JS; Benton C; Doig A; Baird D; Clarke BF
    Metabolism; 1988 Jul; 37(7):656-9. PubMed ID: 3386533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful insulin therapy in lipoatrophic diabetes].
    Böhmer K; Hauner H; Phlippen R; Gries FA
    Dtsch Med Wochenschr; 1991 Mar; 116(12):454-9. PubMed ID: 2004587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Partial lipodystrophy syndrome (Dunnigan type)].
    Hook B; Freudlsperger F; Adam W; Seif FJ
    Hautarzt; 1984 Oct; 35(10):530-5. PubMed ID: 6500935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
    Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
    F1000Res; 2019; 8():. PubMed ID: 31656583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to the Patient With Lipodystrophy.
    Fourman LT; Grinspoon SK
    J Clin Endocrinol Metab; 2022 May; 107(6):1714-1726. PubMed ID: 35137140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for type 2 diabetes in children with acanthosis nigricans.
    Hardin DS
    Diabetes Educ; 2006; 32(4):547-52. PubMed ID: 16873592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.